In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Northstar Neuroscience completes $113.9mm IPO

08 Jun 2006

Executive Summary

Northstar Neuroscience (developing an implantable stimulation system to help patients recover from stroke) has sold 8.17mm common shares (including the overallotment) at $15 apiece, netting $113.9mm. The company had initially anticipated a smaller offering of 6mm shares at $12-14, which would have brought in only $78mm.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Radiofrequency Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By